Cargando…
Experience with Alendronate Treatment for Four Years among Japanese Men with Osteoporosis or Osteopenia and Clinical Risk Factors for Fractures [Retraction]
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9375997/ https://www.ncbi.nlm.nih.gov/pubmed/35975129 http://dx.doi.org/10.2147/TCRM.S385426 |
Ejemplares similares
-
Experience with alendronate treatment for four years among Japanese men with osteoporosis or osteopenia and clinical risk factors for fractures
por: Iwamoto, Jun, et al.
Publicado: (2010) -
Experience with alendronate treatment for four years among Japanese men with osteoporosis or osteopenia and clinical risk factors for fractures [Expression of concern]
Publicado: (2018) -
Retraction: Paper “Comparison of the Effects of Alendronate and Alfacalcidol on Hip Bone Mineral Density and Bone Turnover in Japanese Men Having Osteoporosis or Osteopenia with Clinical Risk Factors for Fractures” by Iwamoto J, et al. [Yonsei Med J 2009 Aug;50(4):474-481]
Publicado: (2023) -
Five-year alendronate treatment outcome in older postmenopausal Japanese women with osteoporosis or osteopenia and clinical risk factors for fractures
por: Iwamoto, Jun, et al.
Publicado: (2009) -
Comparison of the Effects of Alendronate and Alfacalcidol on Hip Bone Mineral Density and Bone Turnover in Japanese Men Having Osteoporosis or Osteopenia with Clinical Risk Factors for Fractures
por: Iwamoto, Jun, et al.
Publicado: (2009)